• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia.天然头发补充剂:有益还是有害?锯棕榈,一项关于脱发的系统评价
Skin Appendage Disord. 2020 Nov;6(6):329-337. doi: 10.1159/000509905. Epub 2020 Aug 23.
2
Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects - A 16-Week Randomized, Placebo-Controlled Study.标准化锯棕榈油的口服和局部给药可减少雄激素性脱发患者的脱发并促进头发生长——一项为期16周的随机、安慰剂对照研究。
Clin Cosmet Investig Dermatol. 2023 Nov 11;16:3251-3266. doi: 10.2147/CCID.S435795. eCollection 2023.
3
Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.一种含有氨基酸、铁、硒和海洋水解胶原蛋白的口服补充剂在脱发患者(雄激素性脱发、AGA 或 FAGA 或休止期脱发)中的疗效和耐受性。一项前瞻性、随机、3 个月、对照、评估者盲法研究。
Skin Res Technol. 2023 Jun;29(6):e13381. doi: 10.1111/srt.13381.
4
Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment.女性休止期脱发的口服补充治疗:一种新型口服美容疗法疗效和耐受性的临床及仪器客观证据
Ital J Dermatol Venerol. 2023 Feb;158(1):55-59. doi: 10.23736/S2784-8671.22.07416-3. Epub 2023 Jan 16.
5
Complementary and alternative supplements: a review of dermatologic effectiveness for androgenetic alopecia.补充和替代补充剂:雄激素性脱发的皮肤科疗效综述。
Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):111-117. doi: 10.1080/08998280.2023.2263829. eCollection 2024.
6
A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia.局部应用Procapil联合富血小板血浆疗法与局部应用Redensyl、锯棕榈和生物素联合富血小板血浆疗法治疗雄激素性脱发的对比研究。
Cureus. 2023 May 8;15(5):e38696. doi: 10.7759/cureus.38696. eCollection 2023 May.
7
Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.ALRV5XR治疗雄激素性脱发或休止期脱发女性的安全性和有效性:一项随机、双盲、安慰剂对照临床试验。
EClinicalMedicine. 2021 Jun 24;37:100978. doi: 10.1016/j.eclinm.2021.100978. eCollection 2021 Jul.
8
Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.一项关于局部再生治疗在休止期脱发和轻度雄激素性脱发患者中的疗效和耐受性的临床研究。
J Cosmet Dermatol. 2023 Dec;22(12):3347-3351. doi: 10.1111/jocd.15873. Epub 2023 Jul 6.
9
Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.红色发光二极管光疗法治疗患有和不患有雄激素性脱发的长期新冠患者的休止期脱发
Ann Agric Environ Med. 2024 Jun 27;31(2):239-247. doi: 10.26444/aaem/177238. Epub 2024 Jan 8.
10
The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study.通过离子电渗疗法运载的预制生长因子对雄激素性脱发和休止期脱发患者的有效性和耐受性:一项临床研究。
Dermatol Pract Concept. 2021 May 20;11(3):e2021082. doi: 10.5826/dpc.1103a82. eCollection 2021 May.

引用本文的文献

1
Topical Alternatives for Hair Loss: Beyond the Conventional.脱发的局部治疗替代方法:超越传统方法。
Int J Trichology. 2025 Jan-Feb;17(1):13-19. doi: 10.4103/ijt.ijt_8_23. Epub 2025 Jun 23.
2
What do users in a polycystic ovary syndrome (PCOS) forum think about the treatments they tried: Analysing treatment sentiment using machine learning.多囊卵巢综合征(PCOS)论坛中的用户对他们尝试过的治疗方法有何看法:使用机器学习分析治疗情绪。
Phys Eng Sci Med. 2025 Apr 14. doi: 10.1007/s13246-025-01539-9.
3
A Qualitative Review of Misinformation on Alopecia.关于脱发错误信息的定性综述
Skin Appendage Disord. 2025 Apr;11(2):182-185. doi: 10.1159/000541809. Epub 2024 Nov 5.
4
Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia.临床相关常见脱发形式的局部治疗进展
Life (Basel). 2024 Dec 1;14(12):1577. doi: 10.3390/life14121577.
5
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair.一项随机、双盲、安慰剂对照研究,旨在评估一种含有标准化植物成分的营养补充剂对男性头发稀疏的安全性和有效性。
J Cosmet Dermatol. 2025 Jan;24(1):e16778. doi: 10.1111/jocd.16778.
6
A Narrative Review of Herbal Remedies for Managing Hirsutism.一篇关于治疗多毛症的草药疗法的叙述性综述。
Int J Prev Med. 2024 Mar 28;15:17. doi: 10.4103/ijpvm.ijpvm_62_23. eCollection 2024.
7
Complementary and alternative supplements: a review of dermatologic effectiveness for androgenetic alopecia.补充和替代补充剂:雄激素性脱发的皮肤科疗效综述。
Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):111-117. doi: 10.1080/08998280.2023.2263829. eCollection 2024.
8
A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia.局部应用Procapil联合富血小板血浆疗法与局部应用Redensyl、锯棕榈和生物素联合富血小板血浆疗法治疗雄激素性脱发的对比研究。
Cureus. 2023 May 8;15(5):e38696. doi: 10.7759/cureus.38696. eCollection 2023 May.
9
Biomolecules of Fermented Tropical Fruits and Fermenting Microbes as Regulators of Human Hair Loss, Hair Quality, and Scalp Microbiota.发酵热带水果及其发酵微生物中的生物分子作为调控人类脱发、发质和头皮微生物组的物质。
Biomolecules. 2023 Apr 20;13(4):699. doi: 10.3390/biom13040699.
10
DeepBiomarker: Identifying Important Lab Tests from Electronic Medical Records for the Prediction of Suicide-Related Events among PTSD Patients.深度生物标志物:从电子病历中识别重要实验室检查以预测创伤后应激障碍患者自杀相关事件
J Pers Med. 2022 Mar 24;12(4):524. doi: 10.3390/jpm12040524.

本文引用的文献

1
Serenoa repens extracts promote hair regeneration and repair of hair loss mouse models by activating TGF-β and mitochondrial signaling pathway.荷叶蒲桃提取物通过激活 TGF-β 和线粒体信号通路促进毛发生长和修复脱发模型鼠。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):4000-4008. doi: 10.26355/eurrev_201806_15285.
2
A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair.一项为期六个月的随机双盲安慰剂对照研究,评估一种营养补充剂对自我感觉头发稀疏的女性促进头发生长的安全性和有效性。
J Drugs Dermatol. 2018 May 1;17(5):558-565.
3
A Novel Multi-Targeting Approach to Treating Hair Loss, Using Standardized Nutraceuticals.一种使用标准化营养保健品治疗脱发的新型多靶点方法。
J Drugs Dermatol. 2017 Nov 1;16(11):s141-s148.
4
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report.锯叶棕作为一名10岁年轻女孩的内分泌干扰物:一则新病例报告
Pharmacology. 2015;96(1-2):41-3. doi: 10.1159/000431327. Epub 2015 Jun 2.
5
Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.使用含锯叶棕提取物的局部用产品治疗男性雄激素性脱发。
Australas J Dermatol. 2016 Aug;57(3):e76-82. doi: 10.1111/ajd.12352. Epub 2015 May 25.
6
A phytochemical comparison of saw palmetto products using gas chromatography and (1) H nuclear magnetic resonance spectroscopy metabolomic profiling.使用气相色谱法和(1)H核磁共振光谱代谢组学分析对锯棕榈产品进行植物化学比较。
J Pharm Pharmacol. 2014 Jun;66(6):811-22. doi: 10.1111/jphp.12198. Epub 2014 Jan 13.
7
Hair loss and herbs for treatment.脱发与草药治疗。
J Cosmet Dermatol. 2013 Sep;12(3):210-22. doi: 10.1111/jocd.12051.
8
Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study.非那雄胺与锯叶棕在男性雄激素性脱发中的疗效比较:一项为期两年的研究。
Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):1167-73. doi: 10.1177/039463201202500435.
9
Serenoa repens for benign prostatic hyperplasia.用于良性前列腺增生的锯叶棕。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3.
10
Long-term drug treatment of benign prostatic hyperplasia - results of a prospective 3-year multicenter study using Sabal extract IDS 89.良性前列腺增生的长期药物治疗 - 使用沙巴棕提取物 IDS 89 的前瞻性 3 年多中心研究结果。
Phytomedicine. 1996 Sep;3(2):105-11. doi: 10.1016/S0944-7113(96)80023-7.

天然头发补充剂:有益还是有害?锯棕榈,一项关于脱发的系统评价

Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia.

作者信息

Evron Evyatar, Juhasz Margit, Babadjouni Arash, Mesinkovska Natasha Atanaskova

机构信息

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Department of Dermatology, University of California, Irvine, Irvine, California, USA.

出版信息

Skin Appendage Disord. 2020 Nov;6(6):329-337. doi: 10.1159/000509905. Epub 2020 Aug 23.

DOI:10.1159/000509905
PMID:33313047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7706486/
Abstract

Saw palmetto (SP), a botanical extract with antiandrogenic properties, has gained commercial popularity for its purported benefits on hair regrowth. To summarize published evidence on the efficacy, safety, and tolerability of supplements containing SP in the treatment of alopecia, we conducted a PubMed, Google Scholar, and Cochrane database search using the following terms: (saw palmetto and hair loss), (saw palmetto and androgenetic alopecia), and (saw palmetto and natural supplement and alopecia). Five randomized clinical trials (RCTs) and 2 prospective cohort studies demonstrated positive effects of topical and oral supplements containing SP (100-320 mg) among patients with androgenetic alopecia (AGA) and telogen effluvium. Sixty percent improvement in overall hair quality, 27% improvement in total haircount, increased hair density in 83.3% of patients, and stabilized disease progression among 52% were noted with use of various topical and oral SP-containing supplements. SP was well tolerated and not associated with serious adverse events in alopecia patients. Although robust high-quality data are lacking, supplements containing SP may be a treatment option for patients with AGA, telogen effluvium, and self-perceived hair thinning. Further large-scale RCTs focusing on the sole contribution of SP to hair growth outcomes are needed to confirm efficacy and determine long-term adverse events.

摘要

锯棕榈(SP)是一种具有抗雄激素特性的植物提取物,因其据称对头发生长的益处而在商业上颇受欢迎。为了总结已发表的关于含锯棕榈补充剂治疗脱发的疗效、安全性和耐受性的证据,我们使用以下术语在PubMed、谷歌学术和Cochrane数据库中进行了搜索:(锯棕榈和脱发)、(锯棕榈和雄激素性脱发)以及(锯棕榈和天然补充剂和脱发)。五项随机临床试验(RCT)和两项前瞻性队列研究表明,含锯棕榈(100 - 320毫克)的局部和口服补充剂对雄激素性脱发(AGA)和休止期脱发患者有积极作用。使用各种含锯棕榈的局部和口服补充剂后,总体头发质量改善了60%,总头发数量增加了27%,83.3%的患者头发密度增加,52%的患者疾病进展得到稳定。锯棕榈耐受性良好,在脱发患者中未发现与严重不良事件相关。尽管缺乏有力的高质量数据,但含锯棕榈的补充剂可能是AGA、休止期脱发和自我感觉头发稀疏患者的一种治疗选择。需要进一步开展大规模的RCT,重点关注锯棕榈对头发生长结果的单独作用,以确认疗效并确定长期不良事件。